NETs in sickle cell disease, quo vadis?

Blood. 2022 Sep 1;140(9):938-939. doi: 10.1182/blood.2022017346.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Humans
  • Liver
  • Lung
  • Lung Injury*
  • Receptor Protein-Tyrosine Kinases

Substances

  • Receptor Protein-Tyrosine Kinases